Literature DB >> 13378052

Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects.

I P ACKERMAN, J W CONN, S S FAJANS, R D GITTLER, A R HENNES, R D JOHNSON, L H LOUIS, H S SELTZER, B L WAJCHENBERG.   

Abstract

Entities:  

Keywords:  SULFANILAMIDE/related compounds; SULFONAMIDES/effects; UREA/related compounds

Mesh：

Substances：

Year:  1956        PMID： 13378052

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Addison's disease complicating diabetes.

Authors:  F M BOURNE; R P HOWARD
Journal:  Can Med Assoc J       Date:  1963-02-16       Impact factor: 8.262

2.  Oral hypoglycaemic drugs.

Authors:  J D SLATER
Journal:  Postgrad Med J       Date:  1959-05       Impact factor: 2.401

3.  The hypoglycaemic sulphonylureas.

Authors:  G WALKER
Journal:  Postgrad Med J       Date:  1957-05       Impact factor: 2.401

4.  Clinical experience with tolbutamide.

Authors:  G WALKER; J D SLATER; E K WESTLAKE; J D NABARRO
Journal:  Br Med J       Date:  1957-08-10

5.  [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin].

Authors:  A Appels; R Kattermann; H Proschek; K Hubrich; H Frerichs; H D Söling; W Creutzfeldt
Journal:  Diabetologia       Date:  1968-08       Impact factor: 10.122

6.  [17-hydroxy-corticosterone level in the blood during treatment with N1-sulfanilyl-N2-N-buthylcarbamide].

Authors:  J G RAUSCH-STROOMANN; H SAUER
Journal:  Klin Wochenschr       Date:  1957-05-15

7.  The action of hypoglycaemic sulphonylureas on carbohydrate metabolism in the fasted rat.

Authors:  I K FRY; P H WRIGHT
Journal:  Br J Pharmacol Chemother       Date:  1957-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.